natgillin/translations-raw huggingface dataset:
Even if you develop a preference for one site, you still should rotate the injection site.
Mesta injiciranja morate menjavati, tudi če vam je katero najljubše.
Even if you feel better, do not alter or discontinue the daily dose of ABILIFY oral solution without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not alter or discontinue the daily dose of ABILIFY orodispersible tablets without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY orodisperzibilne tablete, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not alter or discontinue the daily dose of ABILIFY tablets without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila ABILIFY, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Mylan Pharma tablets without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Mylan Pharma, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Sandoz tablets without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Sandoz tablete, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not stop taking Norvir without talking to your doctor.
Tudi če se počutite bolje, ne nehajte jemati zdravila Norvir, ne da bi se posvetovali s svojim zdravnikom.
Even if you feel better, do not stop taking PREZISTA and cobicistat or ritonavir without talking to your doctor.
Tudi če se počutite bolje, zdravila PREZISTA in kobicistata ali ritonavirja ne smete prenehati jemati, ne da bi se prej posvetovali z zdravnikom.
Even if you feel better, do not stop taking PREZISTA and cobicistat or ritonavir without talking to your doctor.
Tudi, če se počutite bolje, ne prenehajte jemati zdravila PREZISTA in kobicistata ali ritonavirja, ne da bi se prej posvetovali s svojim zdravnikom.
Even if you have previously tolerated oral risperidone or oral paliperidone, rarely allergic reactions occur after receiving injections of paliperidone. are planning to have an operation on your eye, make sure you tell your eye doctor that you are taking this medicine.
Tudi če ste dobro prenašali peroralni risperidon ali peroralni paliperidon, se redko lahko po injiciranju paliperidona pojavijo alergijske reakcije. če načrtujete operacijo na očesu, okulistu ne pozabite povedati, da prejemate to zdravilo.
Even if you have previously tolerated oral risperidone or oral paliperidone, rarely allergic reactions occur after receiving injections of Xeplion.
Tudi če ste dobro prenašali peroralni risperidon ali peroralni paliperidon, se redko lahko po injiciranju zdravila Xeplion pojavijo alergijske reakcije.
Even in the absence of factor IX inhibitor, higher doses of BeneFIX may be needed than required for other plasma-derived factor IX products that you may have taken previously.
Celo v odsotnosti inhibitorja faktorja IX utegnejo biti potrebni večji odmerki zdravila BeneFIX, kot so potrebni za druga zdravila, ki vsebujejo faktor IX, pridobljen iz plazme, in ki ste jih morda jemali pred tem.
Even numbers are shown in line with the dose pointer:
Soda števila so prikazana kot uravnana s kazalnikom odmerka:
Even on therapy, acute hyperammonaemic encephalopathy may occur in a number of patients.
Pri številnih bolnikih se lahko akutna hiperamonemična encefalopatija pojavi celo med zdravljenjem.
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction)
Tudi pri bolnikih, ki nimajo gena HLA-B*5701, se lahko pojavi preobčutljivostna reakcija (huda alergijska reakcija).
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction), described in this leaflet in the panel headed ‘Hypersensitivity reactions’.
Celo bolniki, ki nimajo gena HLA-B*5701, lahko vseeno razvijejo preobčutljivostno reakcijo (hudo alergijsko reakcijo), ki je opisana v tem navodilu pod naslovom »Preobčutljivostne reakcije«.
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction), described in this leaflet in the panel headed ‘Hypersensitivity reactions’.
Tudi pri bolnikih, ki nimajo gena HLA-B*5701, se lahko pojavi preobčutljivostna reakcija (huda alergijska reakcija), ki je v tem navodilu opisana pod naslovom »Preobčutljivostne reakcije«.
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction), described in this leaflet in the panel headed ‘Hypersensitivity reactions’.
Tudi pri bolnikih, ki nimajo gena HLA-B*5701, se lahko pojavi preobčutljivostna reakcija (resna alergijska reakcija), ki je v tem navodilu opisana pod naslovom »Preobčutljivostne reakcije«.
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction).
Celo bolniki, ki nimajo gena HLA-B*5701, lahko vseeno razvijejo preobčutljivostno reakcijo (hudo alergijsko reakcijo).
Even patients who don’t have the HLA-B*5701 gene may still develop a hypersensitivity reaction (a serious allergic reaction).
Tudi pri bolnikih, ki nimajo gena HLA-B*5701, se lahko pojavi preobčutljivostna reakcija (resna alergijska reakcija).
Even those few patients with trough asparaginase serum activity levels of 10 – 100 U/l usually experienced complete asparagine depletion in serum and CSF.
Celo pri tistih nekaj bolnikih, ki so imeli najnižjo raven serumske aktivnosti asparaginaze 10-100 E/l, je navadno bilo prisotno popolno izčrpanje asparagina v serumu in CSF.
Even though the proportion of seizure free dogs was lower with Pexion than with phenobarbital, some dogs were well controlled with Pexion.
Čeprav je bil delež psov brez napadov pri zdravilu Pexion nižji kot pri fenobarbitalu, so bili nekateri psi dobro nadzorovani z zdravilom Pexion.
Even with pre-medication, severe reactions, including cytokine release syndrome, have been reported following use of ofatumumab.
Po uporabi ofatumumaba so celo v primeru premedikacije opisane hude reakcije, vključno s sindromom sproščanja citokinov.
Evening
večer
Evening (N= 255)
Zvečer (N = 255)
Evening AUC: +--
AUC zvečer: ↔
Evening Cmin: j 24% (j 3 to j 50) b
Cmin zvečer: ↑ 24 % (↑ 3 do
Evening Cmin: ↑ 24 % (↑ 3 to
Cmin zvečer: ↑ 24 % (↑ 3 do
Evening Cmin: ↑ 24% (↑ 3 to ↑ 50) b
Cmin zvečer: ↑ 24 % (↑ 3 do ↑ 50)b
Evening Cmin: ↑ 24% (↑ 3 to ↑ 50) Efavirenz:
Cmin zvečer: ↑ 24 (↑ 3 do ↑ 50)
Event Category
Vrsta dogodkov
Event count
Števi lo dogo dkov
Event free survival
Preživetje brez dogodka
Event rate (%/year)
pogostnost dogodka (%/leto)
Event rate (%/yr)a
pogostnost dogodka (%/leto)a
Event Rate (%/yr)b
pogostnost dogodka (%/leto)b
Event terms that represent the same medical concept or condition were grouped together and reported as a single adverse reaction in Table 3.
Izrazi za neželene učinke, ki predstavljajo isti zdravstveni pojem ali stanje, so v preglednici 3 združeni in poročani kot en neželeni učinek.
Event*
Dispepsija
Event*
Dogodek
Event**
8,1
Event**
Dogodek
Event-free probability (%), (95% CI)
verjetnost za obdobje brez dogodkov (event-free probability) (%), (95-odstotni IZ)
Events (%) 190 (65.1%) 223 (76.9%)
Dogodki (%) 190 (65,1 %) 223 (76,9 %)
Events (deaths) n (%)
Celokupno preživetje* dogodki (smrti) n (%)
Events (grade 2-4) reported by study investigators as attributable to study medication and occurring in >1% of patients, are included as well as grade 3-4 treatment emergent laboratory abnormalities.
Vključeni so tako neželeni učinki (stopnje 2–4), ki so se pojavili pri > 1 % bolnikov in so jih raziskovalci, ki so o njih poročali, pripisali preučevanemu zdravilu, kot tudi laboratorijska odstopanja stopnje 3–4, ki so bila povezana z zdravljenjem.
events (MACE) in overweight and obese subjects.
neželenih učinkov (MACE) pri preiskovancih s čezmerno telesno maso in debelih preiskovancih.
Events 183 (45) 215 (52)
Dogodki 183 (45) 215 (52)
Events 50 (23.8) 96 (46.2)
Dogodki 50 (23,8) 96 (46,2)
Events 86 (63.7) 113 (82.5)
Dogodki 86 (63,7) 113 (82,5)
Events [N(%)]
Dogodki [n(%)]
Events associated with coagulopathy
dogodkov, povezanih s koagulopatijo
Events included rash, fever, nausea and vomiting, chills, rigors, low blood pressure and elevated serum liver transaminases in various combinations, and possibly primary immune complex reaction, respiratory distress and glomerulonephritis.
Dogodki so vključevali osip, vročino, slabost in bruhanje, mrzlico, rigor, nizek krvni tlak in povišane serumske koncentracije jetrnih transaminaz v različnih kombinacijah in možno primarno reakcijo imunskih kompleksov, dihalno stisko ter glomerulonefritis.
Events n (%)
dogodki n (%)
Events n (%)
≥ 90% n (%)
Events not reported in registration studies and cannot be estimated from the available data.
O dogodkih v študijah za pridobitev dovoljenja za promet niso poročali in o njih ne moremo predvidevati na osnovi podatkov, ki so na voljo.
Events noted as having a frequency not known were identified via post-marketing surveillance
Učinke z navedbo pogostnosti "neznana" so ugotovili med nadzorom po začetku trženja zdravila.
Events noted as having frequency “Not known” were identified via post-marketing surveillance.
Dogodki z neznano pogostnostjo so bili opaženi v obdobju spremljanja zdravila po prihodu na trg..
Events of diverticular perforations as complications of diverticulitis have been reported uncommonly with RoActemra in RA patients (see section 4.8).
Občasno so pri zdravljenju bolnikov z revmatoidnim artritisom z zdravilom RoActemra poročali o perforaciji divertiklov kot zapletu divertikulitisa (glejte poglavje 4.8).
Events of interest to the class
Dogodki, pomembni za skupino zdravil
Events of neutropenia were observed with MabThera treatment, the majority of which were transient and mild or moderate in severity.
Pri zdravljenju z zdravilom MabThera so opazili dogodke nevtropenije, ki so bili večinoma prehodni in po resnosti blagi ali zmerni.
Events of osteonecrosis of the jaw (ONJ) have been observed with cabozantinib.
Pri uporabi kabozantiniba so opazili dogodke osteonekroze čeljusti.
Events of rash after vaccination (related cases observed in 0.64% of subjects) with IMVANEX tend to occur within the first days after vaccination, are mild to moderate in intensity and usually resolve without sequelae.
Dogodki z izpuščajem po cepljenju (zadevne primere so opazili pri 0,64 % oseb) s cepivom IMVANEX se pojavljajo v prvih dneh po cepljenju, so po intenzivnosti blagi do zmerni in običajno izzvenijo brez posledic.
Events of venous thromboembolism, including pulmonary embolism, and events of arterial thromboembolism have been observed with cabozantinib.
Pri uporabi kabozantiniba, so opazili dogodke venske trombembolije, vključno s pljučno embolijo in dogodke arterijske trombembolije.
Events related to the nervous system (e.g. epileptic seizure, convulsion, aphasia, speech disorder, delirium, acute brain syndrome, agitation, confusion, depression, psychosis)
dogodki, povezani z živčevjem (npr. epileptični napad, krči, afazija, motnje govora, delirij, akutni organski psihosindrom, agitacija, zmedenost, depresija, psihoza)
Events related to the nervous system (e.g. epileptic seizure, convulsion, speech disorder, delirium, agitation, confusion, depression, psychosis) severe allergic reaction, causing shock or collapse
dogodki, povezani z živčevjem (npr. epileptični napad, krči, motnje govora, delirij, agitacija, zmedenost, depresija, psihoza), resna alergijska reakcija, ki povzroči šok ali kolaps.
Events that generally have early onset include hypocalcaemia, hypokalaemia, thrombocytopenia, hypertension, palmar- plantar erythrodysaesthesia syndrome (PPES), and gastrointestinal (GI) events (abdominal or mouth pain, mucosal inflammation, constipation, diarrhoea, vomiting).
Dogodki, ki se običajno pojavijo zgodaj, vključujejo hipokalciemijo, hipokaliemijo, trombocitopenijo, hipertenzijo, sindrom palmarno-plantarne eritrodisestezije (PPES, palmar-plantar erythrodysaesthesia syndrome) in gastrointestinalni (GI) dogodki (bolečine v trebuhu ali ustih, vnetje sluznice, zaprtje, driska, bruhanje.
Events that generally have early onset include hypocalcaemia, hypokalaemia, thrombocytopenia, hypertension, palmar-plantar erythrodysaesthesia syndrome (PPES), proteinuria, and gastrointestinal (GI) events (abdominal pain, mucosal inflammation, constipation, diarrhoea, vomiting).
Dogodki, ki se običajno pojavijo zgodaj, vključujejo hipokalciemijo, hipokaliemijo, trombocitopenijo, hipertenzijo, sindrom palmarno- plantarne eritrodisestezije (PPES, palmar-plantar erythrodysaesthesia syndrome) proteinurijo in gastrointestinalne (GI) dogodke (bolečine v trebuhu, vnetje sluznice, zaprtje, driska, bruhanje).
events usually associated with these
učinke, ki se običajno pojavljajo pri
Events were reported at various time points during treatment and may occur several weeks to several years after starting treatment with interferon beta.
O dogodkih so poročali v različnih časovnih točkah med zdravljenjem in se lahko pojavijo po več tednih do več let po začetku zdravljenja z interferonom beta.
Events were reported at various time points including up to several years after starting treatment with interferon beta
O dogodkih so poročali ob različnih časovnih točkah do vključno nekaj let po začetku zdravljenja z interferonom beta.
events/subjects Event Rate
Delež dogodkov
Events: POM+LD-DEX=164/302 HD-DEX=103/153
Dogodki: POM+NO-deks = 164/302 VO-deks = 103/153
Eventually, the amyloid causes the symptoms of this disease.
Sčasoma lahko pride do tega, da amiloid povzroči simptome te bolezni.
ever had an allergic reaction to diphtheria toxoid (a substance used in a number of other vaccines) an illness with high fever.
kadar koli imeli alergijsko reakcijo na toksoid davice (snov, ki se uporablja v številnih drugih cepivih) bolni in imate zvišano telesno temperaturo.
ever had an allergic reaction to the active substances or any of the other ingredients of this vaccine (listed in section 6)
kadar koli imeli alergijsko reakcijo na zdravilne učinkovine ali katero koli drugo sestavino tega cepiva (navedeno v poglavju 6)
ever had loss of vision because of non-arteritic anterior ischemic optic neuropathy (NAION), a condition described as “stroke of the eye”.
ste kadarkoli izgubili vid zaradi nearteritične anteriorne ishemične optične nevropatije (NAION), stanje, ki je opisano kot "očesna kap".
Ever smoker
Kajenje kdaj
evere
hud
evere
huda
evere abdominal pain or constipation (uncommon)
hudo bolečino v trebuhu ali zaprtost (občasno),
evere abdominal pain with or without back pain
huda bolečina v trebuhu z ali brez bolečine v hrbtu,
evere abdominal swelling and pain in the stomach area (abdomen)
hudo napihnjenost trebuha in bolečine v predelu trebuha (abdomna),
evere acute infectious diseases such as tuberculosis, or acute hepatitis
resne akutne infekcijske bolezni, kot sta tuberkuloza ali akutni hepatitis,
evere adverse skin reactions ear pain, discharge from the ear, and/or an ear infection.
hude neželene kožne reakcije. bolečine v ušesu, izcedka iz ušesa in/ali okužbe ušesa.
evere allergic reaction
huda alergijska reakcija
evere allergic reaction
hude alergijske reakcije;
evere allergic reaction (anaphylactic reaction)
anafilaktična reakcija
evere allergic reaction (anaphylactic reaction)
huda alergijska reakcija (anafilaktična reakcija)
evere allergic reaction (anaphylactic reaction) signs of which may include difficulty breathing, chest pain or chest tightness, and/or feeling dizzy/faint, severe itching of the skin or raised lumps on the skin, swelling of the face, lips, tongue and /or throat, which may cause difficulty in swallowing, collapse
znaki hude alergijske reakcije (anafilaktična reakcija), ki lahko vključujejo oteženo dihanje, bolečino ali tiščanje v prsih in/ali omotico/omedlevico, hudo srbenje kože ali dvignjene bulice na koži, otekanje obraza, ustnic, jezika in/ali grla, kar lahko povzroči oteženo požiranje, kolaps
evere allergic reaction (angioedema); signs include swelling mainly of the tongue, lips, face or throat
huda alergijska reakcija (angioedem), med znaki so zlasti otekanje jezika, ustnic, obraza ali grla
evere allergic reaction characterised by fever, swollen mouth, face, lip or tongue, shortness of breath, itching, skin rash and sometimes drop in blood pressure
huda alergijska reakcija, za katero so značilni zvišana telesna temperatura, otekla ustna sluznica, obraz, ustnice ali jezik, zadihanost, srbenje, kožni izpuščaj in včasih tudi znižanje krvnega tlaka
evere allergic reaction characterised by fever, swollen mouth, face, lip or tongue, shortness of breath, itching, skin rash and sometimes drop in blood pressure
resne alergijske reakcije za katere so značilni vročina, otekla ustna sluznica, obraz, ustnice ali jezik, težko dihanje, srbenje, kožni izpuščaj in včasih tudi znižanje krvnega tlaka
evere allergic reaction characterised by fever, swollen mouth, face, lip or tongue, shortness of breath, itching, skin rash and sometimes drop in blood pressure, allergic reaction
resne alergijske reakcije za katere so značilni vročina, otekla ustna sluznica, obraz, ustnice ali jezik, težko dihanje, srbenje, kožni izpuščaj in včasih tudi znižanje krvnega tlaka, alergijska reakcija
evere allergic reaction with shock
hude alergijske rekcije s šokom
evere allergic reaction with shock;
huda alergijska reakcija s šokom;
evere allergic reaction with shock;
hude alergijske reakcije s šokom;
evere allergic reaction with shock;
hude alergijske rekcije s šokom;
evere allergic reactions
hude alergijske reakcije
evere allergic reactions
hude alergijske reakcije;
evere allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling)
hudih alergijskih reakcijah (težave z dihanjem, sopihanje, srbenje, koprivnica in otekanje)
evere allergic reactions (so called anaphylactic reaction which may cause your throat or face to swell, difficulty breathing or a severe rash)
hude alergijske reakcije (tako imenovana anafilaktična reakcija, ki lahko povzroči otekanje grla ali obraza, težave pri dihanju ali hude izpuščaje)
evere allergic reactions which can be recognised by:
hude alergijske reakcije, ki jih je mogoče prepoznati po:
evere allergic reactions ● rash ● pounding or irregular heartbeat
hude alergijske reakcije ● izpuščaj ● razbijanje srca ali nereden srčni utrip
evere allergic reactions,
hude alergijske reakcije,
evere allergic reactions, including widespread blistering rash and skin peeling
hude alergijske reakcije, vključno z izpuščajem z mehurji in lupljenje kože po celem telesu
evere allergic reactions, sometimes with swelling of face or mouth causing difficulty in breathing
hude alergijske reakcije, včasih z oteklostjo obraza ali ust, ki povzroči težko dihanje,
evere allergic skin rash with blisters
hud alergijski izpuščaj na koži z mehurji,
evere and possibly fatal peeling of the skin (toxic epidermal necrolysis)
hudo in lahko tudi smrtno luščenje kože (toksična epidermalna nekroliza)
evere and potentially severe allergic reactions,
hude in potencialno hude alergijske reakcije,
evere ankylosing spondylitis (a disease causing inflammation of the joints of the spine) in adults who have not responded adequately to other treatments; plaque psoriasis (a disease causing red, scaly patches on the skin) in adults with moderate to severe disease and in patients from the age of six years with long-term severe disease;.
hudega ankilozirajočega spondilitisa (bolezni, ki povzroča vnetje in bolečine v sklepih hrbtenice) pri odraslih, ki se niso ustrezno odzvali na druge vrste zdravljenja; psoriaze v plakih (bolezni, ki povzroča rdeče, luskaste zaplate na koži) pri odraslih z zmernim do hudim obolenjem in bolnikih, starejših od šest let, z dolgotrajno hudo boleznijo.
evere axial spondyloarthritis including ankylosing spondylitis; moderate or severe psoriasis
hud aksialni spondilartritis, vključno z ankilozirajočim spondilitisom; zmerno ali hudo luskavico.
evere axial spondyloarthritis including ankylosing spondylitis; moderate or severe psoriasis.
hud aksialni spondilartritis, vključno z ankilozirajočim spondilitisom; zmerno ali hudo luskavico.
evere bleeding from your nose
hude krvavitve iz nosu;
evere bleeding from your nose,
hude krvavitve iz nosu,
evere bleeding from your nose;
hude krvavitve iz nosu;
evere bleeding in the digestive system (such as stomach, gullet or intestine), or the kidneys, vagina and brain heart rhythm disturbance (QT prolongation)
huda krvavitev v prebavilih (npr. v želodcu, požiralniku ali črevesu), ledvicah, nožnici ali možganih, motnje srčnega ritma (podaljšanje intervala QT),
evere breathing difficulties which develop rapidly
hude težave z dihanjem, ki se pojavijo hitro
evere breathing problems
hude težave z dihanjem;
evere breathing problems, trouble breathing during sleep,
težave z dihanjem, težave z dihanjem v spanju
evere cardiac disoders 4 and 6
Srčne bolezni
evere cardiac disorders 4 and 6
hude srčne bolezni 4 in 6
evere cardiac disorders 4 and 6
Srčne bolezni
evere chronic neutropenia (low number of a type of white blood cells) neutropenia (low number of a type of white blood cells) in patients with HIV infection peripheral blood stem cell mobilisation (to stimulate stem cells to enter the blood stream to be collected and used in bone marrow transplantation).
huda kronična nevtropenija (nizko število vrste belih krvnih celic) nevtropenija (nizko število vrste belih krvnih celic) pri bolnikih, okuženih s HIV izplavljanje matičnih celic v periferno kri (za spodbujanje matičnih celic, da vstopijo v krvni obtok, kjer se odvzamejo in uporabijo pri presaditvi kostnega mozga).
evere chronic neutropenia (low white blood cell count); neutropenia in patients with HIV infection; peripheral blood stem cell mobilisation (for blood stem cell donation).
huda kronična nevtropenija (majhno število levkocitov), nevtropenija pri bolnikih, okuženih s HIV, zbiranje matičnih celic iz periferne krvi (za darovanje krvnih matičnih celic).
evere chronic neutropenia, neutropenia in patients with HIV infection, peripheral blood stem cell mobilisation.
huda kronična nevtropenija nevtropenija pri bolnikih, okuženih s HIV zbiranje matičnih celic iz periferne krvi
evere constipation, stomach ulcer, inflamed small intestine and colon, sores in the mouth, bloating
hudo zaprtje, razjeda na želodcu, vnetje tankega in debelega črevesa, razjede v ustih, napihnjenost
evere constipation, stomach ulcer, inflammation of the small intestine and colon, sores in mouth, bloating,
hudo zaprtje, razjeda na želodcu, vnetje tankega in debelega črevesa, razjede v ustih, napihnjenost,
evere constipation, stomach ulcer, inflammation of the small intestine and colon, sores in mouth, bloating,
hudo zaprtje, želodčna razjeda, vnetje tankega in debelega črevesa, razjede v ustih, napihnjenost,
evere diabetes with blood vessel damage
hudo sladkorno bolezen s poškodovanimi krvnimi žilami
evere diarrhea with loss of water from the body serious allergic reactions causing swelling of the face or throat and breathlessness
huda driska z izgubo vode iz telesa, hude alergijske reakcije, ki povzročajo otekanje obraza ali grla in zadihanost.
evere disabling psoriasis, a disease causing red, scaly patches on the skin, when other treatments have not worked well enough; severe psoriatic arthritis, inflammation of the joints that occurs in patients with psoriasis.
hude oslabitvene psoriaze, bolezni, ki povzroča rdeče, luskaste zaplate na koži, ko druge oblike zdravljenja ne delujejo dovolj dobro; hudega psoriatičnega artritisa, vnetja sklepov, ki se pojavlja pri bolnikih s psoriazo.